Exempt Chemical Preparations Under the Controlled Substances Act, 53494-53502 [2022-18794]

Download as PDF 53494 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices written notifications disclosing all changes in membership. On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 15, 2009 (74 FR 34364). The last notification was filed with the Department on February 28, 2022. A corrected notice was published in the Federal Register pursuant to section 6(b) of the Act on July 20, 2022 (87 FR 43298). Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2022–18817 Filed 8–30–22; 8:45 am] BILLING CODE 4410–11–P need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on July 7, 2022, Experic LLC, 2 Clarke Drive, Cranbury, New Jersey 08512–3619, applied to be registered as an importer of the following basic class(es) of controlled substance(s): DEPARTMENT OF JUSTICE Controlled substance Drug Enforcement Administration Marihuana Extract .... Marihuana ................. Tetrahydrocannabinols. Psilocybin ................. 5-Methoxy-N–NDimethyltryptamine. Psilocyn .................... Nabilone ................... [Docket No. DEA–1072] Importer of Controlled Substances Application: Experic LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 30, 2022. Such persons may also file a written request for a hearing on the application on or before September 30, 2022. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 Drug code Schedule 7350 7360 7370 I I I 7437 7431 I I 7438 7379 I II The company plans to import drug code 7437 (Psilocybin) and Psilocyn (7438) as bulk powder and Marihuana Extract (7350), Marihuana (7360) Tetrahydrocannabinols (7370) and Nabilone (7379) as finished dosage units for research and clinical trial purposes. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Kristi O’Malley, Assistant Administrator. [FR Doc. 2022–18744 Filed 8–30–22; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–372] Exempt Chemical Preparations Under the Controlled Substances Act Drug Enforcement Administration, Department of Justice. AGENCY: PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Order with opportunity for comment. ACTION: The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between August 30, 2021, and March 31, 2022, as listed below, were accepted for filing and have been approved or denied as indicated. DATES: Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before October 31, 2022. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. eastern time on the last day of the comment period. ADDRESSES: To ensure proper handling of comments, please reference ‘‘Docket No. DEA–372’’ on all correspondence, including any attachments. Electronic comments: DEA encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment. Paper comments: Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–8201. SUPPLEMENTARY INFORMATION: SUMMARY: Posting of Public Comments Please note that all comments received are considered part of the public record and made available for public inspection online at https:// E:\FR\FM\31AUN1.SGM 31AUN1 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices www.regulations.gov and in the DEA’s public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received. If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase ‘‘PERSONAL IDENTIFYING INFORMATION’’ in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted. If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase ‘‘CONFIDENTIAL BUSINESS INFORMATION’’ in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment. Comments containing personal identifying information and confidential business information identified as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available. Comments posted to https:// www.regulations.gov may include any personal identifying information (such as name, address, and phone number) included in the text of your electronic submission that is not identified as directed above as confidential. An electronic copy of this document is available at https:// www.regulations.gov for easy reference. lotter on DSK11XQN23PROD with NOTICES1 Legal Authority Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 53495 detailed in 21 U.S.C. 811(g)(3)(B).1 The Drug Enforcement Administration (DEA) regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time. specifically described in the application materials received by DEA is exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822–823, 825–829, and 952–954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters. Exempt Chemical Preparation Applications Submitted Between August 30, 2021, and March 31, 2022 DEA received applications between August 30, 2021, and March 31, 2022, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or nonnarcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse and, if the preparation or mixture contains a narcotic controlled substance, is formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects, if abused, and so that the narcotic substance cannot in practice be removed. Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those above mentioned sections of the CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. The requirements set forth in 21 CFR 1308.24(b)–(e) apply to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 21 CFR 1308.24(b)–(e) on a case-bycase basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities. Additional exempt chemical preparation requests received between August 30, 2021, and March 31, 2022, and not otherwise referenced in this order, may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA’s order on such requests will be communicated to the public in a future Federal Register publication. DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957. 1 This authority has been delegated from the Attorney General to the DEA Administrator by 28 CFR 0.100, and subsequently redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 0.104 and section 7 of the appendix to subpart R of part 0. PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Scope of Approval E:\FR\FM\31AUN1.SGM 31AUN1 53496 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices CHART I Product name Form Aalto Scientific, Ltd .................................. Unassayed Chemistry Base Level 1 ............................. Aalto Scientific, Ltd .................................. Unassayed Chemistry Base Level 2 ............................. Aalto Scientific, Ltd .................................. Unassayed Chemistry Base Level 3 ............................. Absolute Absolute Absolute Absolute Absolute Standards, Standards, Standards, Standards, Standards, Inc Inc Inc Inc Inc .......................... .......................... .......................... .......................... .......................... 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: 1 1 1 1 1 1 1 1 1 1 1 1 mL mL mL mL mL mL mL mL mL mL mL mL ........ ........ ........ ........ ........ ........ ........ ........ ........ ........ ........ ........ 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... (-)-D8-THC-D3, 100 ug/mL, in Methanol ....................... (-)-D9-THC-D3, 100 ug/mL, in Ethanol ......................... (-)-D9-THC-D3, 1000 ug/mL, in Ethanol ....................... (+/-)-11-Hydroxy-D9-THC-D3, 100 ug/mL, in Methanol (+/-)-11-Hydroxy-D9-THC-D3, 1000 ug/mL, in Methanol. (+/-)-Amphetamine-D8, 10 ug/mL, in Methanol ............ (+/-)-Amphetamine-D8, 100 ug/mL, in Methanol .......... (+/-)-Amphetamine-D8, 1000 ug/mL, in Methanol ........ (+/-)-Methamphetamine-D8, 100 ug/mL, in Methanol ... (+/-)-Methamphetamine-D8, 1000 ug/mL, in Methanol (+/-)-Methamphetamine-D9, 1000 ug/mL, in Methanol AB-CHMINACA, 100 ug/mL, in Acetonitrile .................. AB-FUBINACA, 100 ug/mL, in Methanol ...................... AB-PINACA, 100 ug/mL, in Methanol ........................... AH-7921, 100 ug/mL, in Methanol ................................ AKB48 (APINACA), 100 ug/mL, in Methanol ................ alpha-Pyrrolidinobutiophenone (alpha-PBP), 100 ug/ mL, in Methanol. AM2201, 100 ug/mL, in Acetonitrile .............................. AM2201, 100 ug/mL, in Methanol ................................. Benzoylecgonine, 10 ug/ml, in Methanol ...................... Benzoylecgonine, 100 ug/ml, in Methanol .................... Benzoylecgonine, 1000 ug/ml, in Methanol .................. Benzoylecgonine-D8, 100 ug/ml, in Methanol .............. Benzoylecgonine-D8, 1000 ug/ml, in Methanol ............ Cocaine-D3, 10 ug/ml, in Methanol .............................. Cocaine-D3, 100 ug/ml, in Methanol ............................ Cocaine-D3, 1000 ug/ml, in Methanol .......................... Codeine-6-b-glucuronide, 10 ug/ml, in acetonitrile:water [1:1]. Codeine-6-b-glucuronide, 100 ug/ml, in acetonitrile:water [1:1]. Codeine-6-b-glucuronide, 1000 ug/ml, in acetonitrile:water [1:1]. d,l-MDEA, 10 ug/ml, in methanol .................................. d,l-MDEA, 100 ug/ml, in methanol ................................ d,l-MDEA, 1000 ug/ml, in methanol .............................. d,l-Methadone, 10 ug/ml, in methanol .......................... d,l-Methadone, 100 ug/ml, in methanol ........................ d,l-Methadone, 1000 ug/ml, in methanol ...................... d,l-Methadone-D3, 10 ug/ml, in methanol ..................... d,l-Methadone-D3, 100 ug/ml, in methanol ................... d,l-Methadone-D3, 1000 ug/ml, in methanol ................. DBP Mix, 100 ug/ml, in MTBE ...................................... DBP Mix, 100 ug/ml, in MTBE ...................................... Dimethyltryptamine, 100 ug/ml, in methanol ................. Dimethyltryptamine, 1000 ug/ml, in methanol ............... d-Propoxyphene, 100 ug/mL, in Methanol .................... d-Propoxyphene, 1000 ug/mL, in Methanol .................. Ecognine methyl ester, 10 ug/ml, in methanol ............. Ecognine methyl ester, 100 ug/ml, in methanol ........... Ecognine methyl ester, 1000 ug/ml, in methanol ......... EPA Method 551 ‘‘Mix B’’, 1000 ug/ml, in MTBE ......... EPA Method 551—Disinfection By-Products Mix #2, 100 ug/ml, in MTBE. EPA Method 551.1—Analytes Mix #2, 100 ug/ml, in MTBE. Fenproporex, 1000 ug/mL, in Methanol ........................ Glass or plastic bottle or flask: 1mL–100 mL; 100mL–500mL; 500mL– 1L. Glass or plastic bottle or flask: 1mL–100 mL; 100mL–500mL; 500mL– 1L. Glass or plastic bottle or flask: 1mL–100 mL; 100mL–500mL; 500mL– 1L. Glass ampoule: 1 mL ........ Glass ampoule: 1 mL ........ Glass ampoule: 1 mL ........ Glass ampoule: 1 mL ........ Glass ampoule: 1 mL ........ Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: 1 1 1 1 1 1 1 1 1 1 1 mL ........ mL ........ ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... 2/14/2022 2/14/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 Glass ampoule: 1 ml ......... 1/10/2022 Glass ampoule: 1 ml ......... 1/10/2022 Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... mL ........ mL ........ ml ......... ml ......... ml ......... ml x 5 ... ml ......... 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 2/14/2022 2/14/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 Glass ampoule: 1 ml ......... 1/10/2022 Glass ampoule: 1 mL ........ 2/14/2022 Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... lotter on DSK11XQN23PROD with NOTICES1 Application date Supplier Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\31AUN1.SGM ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: 31AUN1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3/28/2022 3/28/2022 3/28/2022 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices 53497 CHART I—Continued Supplier Absolute Absolute Absolute Absolute Absolute Absolute Absolute Standards, Standards, Standards, Standards, Standards, Standards, Standards, Inc Inc Inc Inc Inc Inc Inc Product name .......................... .......................... .......................... .......................... .......................... .......................... .......................... Absolute Standards, Inc .......................... Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... lotter on DSK11XQN23PROD with NOTICES1 Absolute Standards, Inc .......................... Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Absolute Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, Standards, VerDate Sep<11>2014 Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc Inc .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... .......................... 16:59 Aug 30, 2022 Jkt 256001 Fenproporex-D5, 1000 ug/mL, in Methanol .................. FUB-144, 100 ug/mL, in Methanol ................................ FUB-AKB48 (FUB-APINACA), 100 ug/mL, in Methanol Heroin-D9, 10 ug/ml, in methanol ................................. Heroin-D9, 100 ug/ml, in methanol ............................... Heroin-D9, 1000 ug/ml, in methanol ............................. Hydrocodone (+)-bitartrate salt, 100 ug/ml, in methanol. Hydrocodone (+)-bitartrate salt, 1000 ug/ml, in methanol. Hydrocodone, 10 ug/ml, in methanol ............................ Hydrocodone, 100 ug/ml, in methanol .......................... Hydrocodone, 1000 ug/ml, in methanol ........................ Hydromorphone, 100 ug/ml, in methanol ...................... Hydromorphone, 1000 ug/ml, in methanol .................... JWH-019, 100 ug/mL, in Methanol ............................... JWH-073, 100 ug/mL, in Acetonitrile ............................ JWH-073, 100 ug/mL, in Methanol ............................... JWH-081, 100 ug/mL, in Methanol ............................... JWH-122, 100 ug/mL, in Methanol ............................... JWH-200, 100 ug/mL, in Methanol ............................... JWH-200-d5, 100 ug/mL, in Acetonitrile ....................... JWH-250, 100 ug/mL, in Methanol ............................... Ketamine, 100 ug/mL, in Methanol ............................... Ketamine, 1000 ug/mL, in Methanol ............................. Ketamine-D4, 1000 ug/mL, in Methanol ....................... Lysergic acid diethylamide (LSD), 100 ug/mL, in Acetonitrile. Lysergic acid diethylamide (LSD), 100 ug/mL, in Acetonitrile. Lysergic acid diethylamide (LSD), 1000 ug/mL, in Acetonitrile. Lysergic acid diethylamide (LSD), 1000 ug/mL, in Acetonitrile. Meperidine, 10 ug/ml, in methanol ................................ Meperidine, 100 ug/ml, in methanol .............................. Meperidine, 1000 ug/ml, in methanol ............................ Mephedrone, 100 ug/ml, in methanol ........................... Mephedrone, 1000 ug/ml, in methanol ......................... Mix A, 1000 ug/ml, in MTBE ......................................... MMB-FUBINACA, 100 ug/mL, in Acetonitrile ............... MMB-FUBINACA, 100 ug/mL, in Methanol .................. Nitrazepam, 100 ug/mL, in Acetonitrile ......................... Nitrazepam, 1000 ug/mL, in Acetonitrile ....................... NM2201, 100 ug/mL, in Acetonitrile .............................. Oxazepam, 10 ug/ml, in acetonitrile ............................. Oxazepam, 10 ug/ml, in methanol ................................ Oxazepam, 100 ug/ml, in methanol .............................. Oxazepam, 1000 ug/ml, in methanol ............................ Oxycodone, 10 ug/ml, in methanol ............................... Oxycodone, 100 ug/ml, in methanol ............................. Oxycodone, 1000 ug/ml, in methanol ........................... Oxycodone-D3, 100 ug/mL, in Methanol ...................... Oxycodone-D3, 1000 ug/mL, in Methanol .................... Oxycodone-D6, 100 ug/mL, in Methanol ...................... Oxycodone-D6, 1000 ug/mL, in Methanol .................... Oxymorphone, 100 ug/mL, in Methanol ........................ Oxymorphone, 1000 ug/mL, in Methanol ...................... Oxymorphone-D3, 100 ug/mL, in Methanol .................. Oxymorphone-D3, 1000 ug/mL, in Methanol ................ PB-22, 100 ug/mL, in Acetonitrile ................................. Phencyclidine-D5, 100 ug/mL, in Methanol .................. Phencyclidine-D5, 1000 ug/mL, in Methanol ................ Phenylacetone, 1000 ug/mL, in Methanol .................... Pregabalin, 10 ug/mL, in Methanol ............................... Pregabalin, 100 ug/mL, in Methanol ............................. Pregabalin, 1000 ug/mL, in Methanol ........................... Psilocin, 100 ug/ml, in methanol ................................... Psilocin, 1000 ug/ml, in methanol ................................. Psilocybin PT, varied ug/ml, in methanol ...................... RCS-4, 100 ug/mL, in Methanol ................................... PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Application date Form Glass Glass Glass Glass Glass Glass Glass mL ........ mL ........ mL ........ ml ......... ml ......... ml ......... ml ......... 2/14/2022 2/14/2022 2/14/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 Glass ampoule: 1 ml ......... 1/10/2022 Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass ml ......... ml ......... ml ......... ml ......... ml ......... mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 Glass ampoule: 1 mL ........ 2/14/2022 Glass ampoule: 1 mL ........ 2/14/2022 Glass ampoule: 1 mL ........ 2/14/2022 Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 1/10/2022 1/10/2022 1/10/2022 2/14/2022 E:\FR\FM\31AUN1.SGM ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: ampoule: 31AUN1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... mL ........ mL ........ mL ........ mL ........ mL ........ ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... ml ......... mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ mL ........ ml ......... ml ......... ml ......... mL ........ 53498 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices CHART I—Continued Product name Form Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Absolute Standards, Inc .......................... Audit MicroControls, Inc .......................... Audit MicroControls, Inc .......................... Audit MicroControls, Inc .......................... Cerilliant Corporation ............................... Cerilliant Corporation ............................... Cerilliant Corporation ............................... Cerilliant Corporation ............................... Chemtos, LLC .......................................... Glass ampoule: 1 ml ......... Glass ampoule: 1 ml ......... Glass ampoule: 1 ml ......... Glass ampoule: 1 ml ......... Glass ampoule: 1 ml ......... Glass ampoule: 1 mL ........ Glass ampoule: 1 mL ........ Glass ampoule: 1 mL ........ Glass ampoule: 1 mL ........ Kit: 10 bottles, 4 mL each Kit: 5 bottles, 4 mL each ... Plastic bottle: 4mL ............. Glass ampule: 1.0 mL ....... Glass ampule: 1.0 mL ....... Glass ampule: 1.0 mL ....... Glass ampule: 1.0 mL ....... Amber ampule: 1 mL ......... 1/10/2022 1/10/2022 1/10/2022 1/10/2022 1/10/2022 2/14/2022 2/14/2022 2/14/2022 2/14/2022 3/30/2022 3/30/2022 3/30/2022 8/30/2021 2/22/2022 1/11/2022 1/11/2022 3/14/2022 Amber ampule: 1 mL ......... 3/14/2022 Amber ampule: 1 mL ......... 3/14/2022 Amber Amber Amber Amber Amber ampule: ampule: ampule: ampule: ampule: 1 1 1 1 1 mL mL mL mL mL ......... ......... ......... ......... ......... 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: 1 1 1 1 1 1 1 1 1 1 1 1 1 1 mL mL mL mL mL mL mL mL mL mL mL mL mL mL ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 Amber ampule: 1 mL ......... 3/14/2022 Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber Amber ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... ......... 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 Amber ampule: 1 mL ......... 3/14/2022 Amber Amber Amber Amber Amber Amber ampule: ampule: ampule: ampule: ampule: ampule: 1 1 1 1 1 1 mL mL mL mL mL mL ......... ......... ......... ......... ......... ......... 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 Amber Amber Amber Amber ampule: ampule: ampule: ampule: 1 1 1 1 mL mL mL mL ......... ......... ......... ......... 3/14/2022 3/14/2022 3/14/2022 3/14/2022 Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, LLC LLC LLC LLC LLC LLC .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... Chemtos, Chemtos, Chemtos, Chemtos, LLC LLC LLC LLC .......................................... .......................................... .......................................... .......................................... THC-O-acetate, 100 ug/ml, in methanol ....................... THC-O-acetate, 1000 ug/ml, in methanol ..................... THC-O-acetate, varied ug/ml, in methanol ................... Tramadol, 10 ug/ml, in methanol .................................. Tramadol, 100 ug/ml, in methanol ................................ UR-144, 100 ug/mL, in Methanol .................................. XLR-11, 100 ug/mL, in Methanol .................................. Zopiclone, 100 ug/mL, in Acetonitrile ............................ Zopiclone, 1000 ug/mL, in Acetonitrile .......................... Control FLQ Unassayed Chemistry, Level 1 ................ Control FLQ Unassayed Chemistry, Level 1 ................ Control FLQ Unassayed Chemistry, Level 1 ................ (6aR,9R)-delta10-THC .................................................. 5 Part Potency in Beverage .......................................... 6 Part Potency in Solution (Acids) ................................ 8 Part Potency in Solution (Neutrals) ........................... (S)-N,N-dimethylamphetamine HCl (1 mg/mL in methanol). (S)-N,N-dimethylamphetamine-d3 HCl (0.1 mg/mL in methanol). (S)-N,N-dimethylamphetamine-d3 HCl (1 mg/mL in methanol). 2,4-DMMC HCl (1 mg/mL in methanol) ........................ 3,4-DMMC HCl (1 mg/mL in methanol) ........................ 3-MMC HCl (1 mg/mL in methanol) .............................. 4-Cl-PVP HCl (1 mg/mL in methanol) ........................... 4-Methylbuphedrone (4-Me-MABP) HCl (1 mg/mL in methanol). 5F-MDMB–PICA (1 mg/mL in acetonitrile) ................... AB-CHMINACA (1 mg/mL in acetonitrile) ..................... AB-PINACA (1 mg/mL in acetonitrile) ........................... alpha-PHP HBr (1 mg/mL in methanol) ........................ Alphaprodine HCl (1 mg/mL in methanol) .................... Alphaprodine-d5 HCl (0.1 mg/mL in methanol) ............ Alphaprodine-d5 HCl (1 mg/mL in methanol) ............... AM-694 (1 mg/mL in acetonitrile) .................................. Anileridine HCl (1 mg/mL in methanol) ......................... APINACA, AKB48 (1 mg/mL in acetonitrile) ................. bk-MDDMA HCl (Dimethylone) (1 mg/mL in methanol) Diethyltryptamine (DET) (1 mg/mL in methanol) .......... Dimethyltryptamine (DMT) (1 mg/mL in methanol) ....... Dimethyltryptamine-d3 (DMT-d3) (0.1 mg/mL in methanol). Dimethyltryptamine-d3 (DMT-d3) (1 mg/mL in methanol). Dipentylone HCl (bk-DMBDP) (1 mg/mL in methanol) Estazolam (1 mg/mL in methanol) ................................ Estazolam-d5 (0.1 mg/mL in methanol) ........................ Estazolam-d5 (1 mg/mL in methanol) ........................... Flunitrazepam (1 mg/mL in methanol) .......................... Flunitrazepam-d3 (0.1 mg/mL in methanol) .................. Flunitrazepam-d3 (1 mg/mL in methanol) ..................... Ketamine HCl (1 mg/mL in methanol) .......................... Ketamine-d4 HCl (0.1 mg/mL in methanol) .................. Ketamine-d4 HCl (1 mg/mL in methanol) ..................... MAB-CHMINACA (1 mg/mL in acetonitrile) .................. MDMB-CHMICA, MMB-CHMINACA (1 mg/mL in acetonitrile). MMB-CHMICA, AMB-CHMICA (1 mg/mL in acetonitrile). MPHP HCl (1 mg/mL in methanol) ............................... Naphyrone HCl (1 mg/mL in methanol) ........................ N-Ethyl-amphetamine HCl (1 mg/mL in methanol) ....... N-Ethyl-amphetamine-d5 HCl (0.1 mg/mL in methanol) N-ethylhexedrone (NEH) HCl (1 mg/mL in methanol) .. N-ethylhexedrone-d5 (NEH-d5) HCl (0.1 mg/mL in methanol). NM2201, CBL-2201 (1 mg/mL in acetonitrile) .............. PCC (1 mg/mL in acetonitrile) ....................................... Phendimetrazine-d8 (0.1 mg/mL in methanol) .............. Phendimetrazine-d8 (1 mg/mL in methanol) ................. 16:59 Aug 30, 2022 PO 00000 Chemtos, LLC .......................................... Chemtos, LLC .......................................... Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, LLC LLC LLC LLC LLC .......................................... .......................................... .......................................... .......................................... .......................................... Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... Chemtos, LLC .......................................... Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, Chemtos, LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC LLC .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... .......................................... Chemtos, LLC .......................................... lotter on DSK11XQN23PROD with NOTICES1 Application date Supplier VerDate Sep<11>2014 Jkt 256001 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\31AUN1.SGM ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: 31AUN1 1 1 1 1 1 1 1 1 1 1 1 1 mL mL mL mL mL mL mL mL mL mL mL mL 53499 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices CHART I—Continued Supplier Product name Chemtos, LLC .......................................... Chemtos, LLC .......................................... Chemtos, LLC .......................................... Chemtos, LLC .......................................... Chemtos, LLC .......................................... CPI International ...................................... LGC—Dr. Ehrenstorfer ............................ LGC Clinical Diagnostics, Inc .................. LGC Clinical Diagnostics, Inc .................. LGC Clinical Diagnostics, Inc .................. LGC Clinical Diagnostics, Inc .................. LGC Clinical Diagnostics, Inc .................. LGC Clinical Diagnostics, Inc .................. Phenylacetone (1 mg/mL in acetonitrile) ...................... Propylone HCl (bk-3,4-MDPA) (1 mg/mL in methanol) PV8 (PHPP) HCl (1 mg/mL in methanol) ..................... Tenocyclidine (TCP) (1 mg/mL in methanol) ................ THJ-2201 (AM2201) (1 mg/mL in methanol) ................ Custom Hormone Mix, 9-072, 1000 mg/L, 1 mL (ISO 17025). NeoMass CAH Extraction Solution with Internal Standard. NeoMass CAH Mutlilevel Calibrator Dried Blood Spot Calibrator Level 0–7. NeoMass CAH Mutlilevel Controls Dried Blood Spot Controls Level 1–3. NeoMass CAH System suitability Mixture CAH (lyophilized). NeoMass CAH Tuning Mixture CAH (lyophilized) ........ Narcotics Mixture 1 0.02–0.075 μg/mL in Synthetic oral fluid. Narcotics Mixture 2 0.01–0.05 μg/mL in Synthetic oral fluid. Narcotics Mixture 3 0.001–0.01 μg/mL in Synthetic oral fluid. (6aR,9R)-D10-Tetrahydrocannabinol 100 μg/mL in Methanol. (6aR-trans)-D8-Tetrahydrocannabinol acetate 100 μg/ mL in Methanol. Custom Cannabinoid Mixture 10141 1000 ug/mL in Acetonitrile. Custom Cannabinoid Mixture 10142 1000 ug/mL in Acetonitrile. Custom Pharmaceutical Mixture 10147 1000 ug/mL in Acetonitrile. Custom Pharmaceutical Mixture 10148 1000 ug/mL in Acetonitrile. Custom Tramadol hydrochloride 100 μg/mL in Methanol. Trenbolone cyclohexylmethylcarbonate 100 μg/mL in Acetonitrile. Zolpidem tartrate 100 μg/mL in Methanol ..................... Fertility 1 ab Bulk—Level 1 ........................................... Fertility 1 ab Bulk—Level 2 ........................................... Fertility 1 ab Bulk—Level 3 ........................................... Fertility 1 ab Bulk—Level 4 ........................................... Fertility 1 ab Bulk—Level 5 ........................................... Fertility 1 ab WrkBlk—Level 1 ....................................... LGC Clinical Diagnostics, Inc .................. Fertility 1 ab WrkBlk—Level 5 ....................................... LGC LGC LGC LGC LGC LGC Fertility Fertility Fertility Fertility Fertility Fertility LabSystems Diagnostics ......................... LabSystems Diagnostics ......................... LabSystems Diagnostics ......................... LabSystems Diagnostics ......................... LabSystems Diagnostics ......................... LGC ......................................................... LGC ......................................................... LGC ......................................................... LGC—Dr. Ehrenstorfer ............................ LGC—Dr. Ehrenstorfer ............................ LGC—Dr. Ehrenstorfer ............................ LGC—Dr. Ehrenstorfer ............................ LGC—Dr. Ehrenstorfer ............................ LGC—Dr. Ehrenstorfer ............................ LGC—Dr. Ehrenstorfer ............................ lotter on DSK11XQN23PROD with NOTICES1 LGC—Dr. Ehrenstorfer ............................ Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. 1 1 1 1 1 1 re re re re re re Bulk—Level 1 ............................................ Bulk—Level 2 ............................................ Bulk—Level 3 ............................................ Bulk—Level 4 ............................................ Bulk—Level 5 ............................................ WrkBlk—Level 1 ....................................... LGC Clinical Diagnostics, Inc .................. Fertility 1 re WrkBlk—Level 5 ....................................... LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. TDM1 TDM1 TDM1 TDM1 TDM1 TDM1 ab ab ab ab ab ab Bulk—Level 1 ................................................ Bulk—Level 2 ................................................ Bulk—Level 3 ................................................ Bulk—Level 4 ................................................ Bulk—Level 5 ................................................ WrkBlk—Level 1 ............................................ LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. TDM1 TDM1 TDM1 TDM1 TDM1 TDM1 au au au au au au Bulk—Level 1 ................................................ Bulk—Level 2 ................................................ Bulk—Level 3 ................................................ Bulk—Level 4 ................................................ Bulk—Level 5 ................................................ WrkBlk—Level 1 ............................................ VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Application date Form Amber Amber Amber Amber Amber Amber ampule: ampule: ampule: ampule: ampule: ampule: 1 1 1 1 1 1 mL mL mL mL mL mL ......... ......... ......... ......... ......... ......... 3/14/2022 3/14/2022 3/14/2022 3/14/2022 3/14/2022 2/2/2022 Glass vial: 33 mL .............. 1/10/2022 Aluminum pouch: 7 Dried blood spots, 85 μL each. Aluminum pouch: 6 Dried blood spots, 85 μL each. Glass vial: 2 mL ................ 1/10/2022 1/10/2022 1/10/2022 Glass vial: 2 mL ................ 1 kit; 10 × 1 mL amber cryule. 1 kit; 10 × 1 mL amber cryule. 1 kit; 10 × 1 mL amber cryule. Amber Ampule: 1 mL ........ 12/21/2021 Amber Ampule: 1 mL ........ 12/21/2021 Amber ampule: 1 mL ......... 3/4/2022 1 kit; 5 × 1 mL amber ampule. Amber ampule: 1 mL ......... 3/4/2022 1 kit; 5 × 1 mL amber ampule. Glass Ampule: 1 mL .......... 3/4/2022 1/27/2022 Amber Ampule: 1 mL ........ 12/21/2021 Glass Ampule: 1 mL .......... Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Volumetric flask: 200–8000 mL. Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Volumetric flask: 200–8000 mL. Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. 1/27/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 E:\FR\FM\31AUN1.SGM 31AUN1 1/10/2022 3/8/2022 3/8/2022 3/8/2022 3/4/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 53500 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices CHART I—Continued Supplier Product name LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. TDM1 TDM1 TDM1 TDM1 TDM1 TDM1 bc bc bc bc bc bc Bulk—Level 1 ................................................ Bulk—Level 2 ................................................ Bulk—Level 3 ................................................ Bulk—Level 4 ................................................ Bulk—Level 5 ................................................ WrkBlk—Level 1 ............................................ LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. TDM1 TDM1 TDM1 TDM1 TDM1 TDM1 db db db db db db Bulk—Level 1 ................................................ Bulk—Level 2 ................................................ Bulk—Level 3 ................................................ Bulk—Level 4 ................................................ Bulk—Level 5 ................................................ WrkBlk—Level 1 ............................................ LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. TDM1 TDM1 TDM1 TDM1 TDM1 TDM1 ri ri ri ri ri ri GentC GentC GentC GentC GentC GentC LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. TDM1 TDM1 TDM1 TDM1 TDM1 TDM1 ri ri ri ri ri ri TDM TDM TDM TDM TDM TDM LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. TDM1 TDM1 TDM1 TDM1 TDM1 TDM1 vt vt vt vt vt vt Set Set Set Set Set Set LGC LGC LGC LGC LGC LGC LGC LGC LGC Clinical Clinical Clinical Clinical Clinical Clinical Clinical Clinical Clinical Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Diagnostics, Inc Inc Inc Inc Inc Inc Inc Inc Inc .................. .................. .................. .................. .................. .................. .................. .................. .................. Testosterone (TSTO) Stock A 100,000 ng/ml .............. Testosterone (TSTO) Stock B 2,000 ng/ml .................. VALIDATE Fertility 1 Test Set 502ab ........................... VALIDATE Fertility 1 Test Set 502re ............................ VALIDATE TDM1 Test Set 301ab ................................ VALIDATE TDM1 Test Set 301au ................................ VALIDATE TDM1 Test Set 301bc ................................ VALIDATE TDM1 Test Set 301db ................................ VALIDATE TDM1 Test Set 301ri .................................. LGC Clinical Diagnostics, Inc .................. o2si smart solutions ................................. VALIDATE TDM1 Test Set 301vt ................................. Custom Pharmaceutical Mixture, 12–0370, 100 ug/mL, 5 × 1 mL (ISO 17034). Hydrocodone hydrogen (+)-bitartrate as hydrocodone in acetonitrile Solution, 5,000 mg/L PARENT STOCK SOLUTION—NOT FOR SALE. Custom Heroin Standard ............................................... 12198–62–06 ................................................................. 2023 DMPM–01 ............................................................ 2023 DMPM–02 ............................................................ 2023 DMPM–03 ............................................................ 2023 DMPM–05 ............................................................ 2023 DMPM–06 ............................................................ 2023 DMPM–07 ............................................................ 2023 FTC–02 ................................................................ 2023 FTC–03 ................................................................ 2023 FTC–05 ................................................................ 2023 FTC–06 ................................................................ 2023 FTC–07 ................................................................ 2023 FTC–09 ................................................................ 2023 FTC–10 ................................................................ 2023 FTC–11 ................................................................ 2023 FTC–13 ................................................................ 2023 FTC–14 ................................................................ 2023 FTC–15 ................................................................ 2023 OFD–01 ................................................................ o2si smart solutions ................................. lotter on DSK11XQN23PROD with NOTICES1 Form Restek Corporation .................................. RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 PO 00000 Set Set Set Set Set Set Set Set Set Set Set Set Bulk—Level 1 ................................ Bulk—Level 2 ................................ Bulk—Level 3 ................................ Bulk—Level 4 ................................ Bulk—Level 5 ................................ WrkBlk—Level 1 ........................... Bulk—Level 1 .................................. Bulk—Level 2 .................................. Bulk—Level 3 .................................. Bulk—Level 4 .................................. Bulk—Level 5 .................................. WrkBlk—Level 1 .............................. Bulk—Level 1 ........................................... Bulk—Level 2 ........................................... Bulk—Level 3 ........................................... Bulk—Level 4 ........................................... Bulk—Level 5 ........................................... WrkBlk—Level 1 ...................................... Frm 00060 Fmt 4703 Sfmt 4703 Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 3200 mL Volumetric flask: 200–8000 mL. Plastic vial: 25 mL ............. Plastic vial: 25 mL ............. 5 Bottles: 4 mL each ......... 5 Bottles: 4 mL each ......... Kit: 5 Bottles, 3 ml each .... Kit: 5 Bottles, 3 ml each .... Kit: 5 Bottles, 3 ml each .... Kit: 5 Bottles, 3 ml each .... Kit: 5 Bottles, 3 ml each; 5 bottles, 2 mL each. Kit: 5 Bottles, 3 ml each .... 1 Package; 5 × 1 mL amber ampules. Amber ampule: 1 mL ......... Glass ampule: 1.3 mL ....... Glass tube: 7 mL ............... HDPE Bottle: 40 mL .......... HDPE Bottle: 40 mL .......... HDPE Bottle: 40 mL .......... HDPE Bottle: 40 mL .......... HDPE Bottle: 40 mL .......... HDPE Bottle: 40 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... Vial: 2 mL .......................... E:\FR\FM\31AUN1.SGM 31AUN1 Application date 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 1/14/2022 2/11/2022 3/8/2022 3/1/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices 53501 CHART I—Continued lotter on DSK11XQN23PROD with NOTICES1 Supplier RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI RTI International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International International VerDate Sep<11>2014 ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... 16:59 Aug 30, 2022 Jkt 256001 Product name Form 2023 OFD–02 ................................................................ 2023 OFD–03 ................................................................ 2023 OFD–04 ................................................................ 2023 OFD–05 ................................................................ 2023 OFD–06 ................................................................ 2023 OFD–07 ................................................................ 2023 OFD–08 ................................................................ 2023 OFD–10 ................................................................ 2023 OFD–11 ................................................................ 2023 OFD–12 ................................................................ 2023 OFD–13 ................................................................ 2023 OFD–14 ................................................................ 2023 OFD–15 ................................................................ 2023 OFD–16 ................................................................ 2023 OFD–17 ................................................................ 2023 OFD–18 ................................................................ 2023 OFD–19 ................................................................ 2023 OFD–20 ................................................................ 2023 T–02 ..................................................................... 2023 T–03 ..................................................................... 2023 T–04 ..................................................................... 2023 T–05 ..................................................................... 2023 T–06 ..................................................................... 2023 T–07 ..................................................................... 2023 T–08 ..................................................................... 2023 T–11 ..................................................................... 2023 T–12 ..................................................................... 2023 T–14 ..................................................................... 2023 THCB–01 .............................................................. 2023 THCB–02 .............................................................. 2023 THCB–03 .............................................................. 2023 THCB–04 .............................................................. 2023 THCB–05 .............................................................. 2023 THCB–06 .............................................................. 2023 UDS–01 ................................................................ 2023 UDS–02 ................................................................ 2023 UDS–03 ................................................................ 2023 UDS–04 ................................................................ 2023 UDS–05 ................................................................ 2023 UDS–06 ................................................................ 2023 UDS–07 ................................................................ 2023 UDS–08 ................................................................ 2023 UDS–09 ................................................................ 2023 UDS–10 ................................................................ 2023 UDS–11 ................................................................ 2023 UDS–12 ................................................................ 2023 UDS–13 ................................................................ 2023 UDS–14 ................................................................ 2023 UDS–15 ................................................................ 2023 UT–01 ................................................................... 2023 UT–02 ................................................................... 2023 UT–03 ................................................................... 2023 UT–05 ................................................................... 2023 UT–06 ................................................................... 2023 UT–07 ................................................................... 2023 UT–08 ................................................................... 2023 UT–09 ................................................................... 2023 UT–10 ................................................................... 2023 UT–11 ................................................................... 2023 UT–12 ................................................................... 2023 UT–13 ................................................................... 2023 UT–14 ................................................................... 2023 UT–15 ................................................................... 2023 UTCO–01 ............................................................. 2023 ZE–01 ................................................................... 2023 ZE–02 ................................................................... 2023 ZE–03 ................................................................... 2023 ZE–04 ................................................................... 2023 ZE–05 ................................................................... 2023 ZE–06 ................................................................... 2023–OFD–09 ............................................................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... Vial: 2 mL .......................... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... HDPE Bottle: 20 mL .......... Vial: 10 mL ........................ Vial: 10 mL ........................ Vial: 10 mL ........................ Vial: 10 mL ........................ Vial: 10 mL ........................ Vial: 10 mL ........................ HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 10 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 50 mL .......... HDPE Bottle: 40 mL .......... Vial: 5 mL .......................... Vial: 5 mL .......................... Vial: 5 mL .......................... Vial: 5 mL .......................... Vial: 5 mL .......................... Vial: 5 mL .......................... Vial: 2 mL .......................... PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\31AUN1.SGM 31AUN1 Application date 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 3/30/2022 53502 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices CHART I—Continued Supplier Product name RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... RTI International ...................................... Thermo Fisher Scientific .......................... Sample 1 Matrix: Urine ................................................. Sample 2 Matrix: Urine ................................................. Sample 3 Matrix: Plasma .............................................. Sample 4 Matrix: Urine ................................................. Sample 6 Matrix: Whole Blood ..................................... Cascadion SM Antiepileptics Internal Standard ............ The Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II below is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the Application date Form Assistant Administrator has determined that the chemical preparations or mixtures generally described in Chart II below and specifically described in the application materials received by DEA, are not exempt from application of any HDPE tubes: 5 mL HDPE tubes: 5 mL HDPE tubes: 5 mL HDPE tubes: 5 mL HDPE tubes: 5 mL Box: 6 vials, 29 mL ............ ............ ............ ............ ............ each .. 3/7/2022 3/7/2022 3/7/2022 3/7/2022 3/7/2022 3/24/2022 part of the CSA or from application of any part of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date that was provided in the determination letters to the individual requesters. lotter on DSK11XQN23PROD with NOTICES1 CHART II Supplier Product name Form Chemtos, LLC .......................................... CPI International ...................................... ANPP (1 mg/mL in acetonitrile) .................................... Custom Hormone Mix, 9–072, 1000 mg/L, 6 x 1 ml .... LGC Clinical Diagnostics, Inc .................. TDM1 ab WrkBlk—Level 5 ............................................ LGC Clinical Diagnostics, Inc .................. TDM1 au WrkBlk—Level 5 ............................................ LGC Clinical Diagnostics, Inc .................. TDM1 bc WrkBlk—Level 5 ............................................ LGC Clinical Diagnostics, Inc .................. TDM1 db WrkBlk—Level 5 ............................................ LGC Clinical Diagnostics, Inc .................. TDM1 ri GentC Set WrkBlk—Level 5 ........................... LGC Clinical Diagnostics, Inc .................. TDM1 ri TDM Set WrkBlk—Level 5 .............................. LGC Clinical Diagnostics, Inc .................. TDM1 vt Set WrkBlk—Level 5 ...................................... LGC Clinical Diagnostics, Inc .................. Validate TDM Phenobarbital Stock ............................... Amber ampule: 1mL .......... 1 Package; 6 x 1 mL amber ampules. Volumetric flask: 200— 8000 mL. Volumetric flask: 200— 8000 mL. Volumetric flask: 200— 8000 mL. Volumetric flask: 200— 8000 mL. Volumetric flask: 200— 8000 mL. Volumetric flask: 200— 8000 mL. Volumetric flask: 200— 8000 mL. Plastic vial: 150 mL ........... Opportunity for Comment Pursuant to 21 CFR 1308.23(e), any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until she may reconsider the application in light of the comments and objections filed. Thereafter, the Assistant Administrator shall reinstate, revoke, or amend his original order as she determines appropriate. Approved Exempt Chemical Preparations are Posted on the DEA’s Website A list of all current exemptions, including those listed in this order, is available on the DEA’s website at https:// VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 www.DEAdiversion.usdoj.gov/ schedules/exempt/exempt_chemlist.pdf. The dates of applications of all current exemptions are posted for easy reference. Kristi O’Malley, Assistant Administrator. [FR Doc. 2022–18794 Filed 8–30–22; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act On August 25, 2022, the Department of Justice lodged a proposed Consent Decree with the United States District Court for the District of Utah in the lawsuit entitled United States v. United Park City Mines Company, Civil Action No. 2:19–cv–00200–BSJ. PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Application date 3/14/2022 1/14/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 3/21/2022 The United States filed this lawsuit against United Park City Mines Company (‘‘UPCM’’) under the Comprehensive Environmental Response, Compensation, and Liability Act (‘‘CERCLA’’). The complaint seeks recovery of costs that the United States incurred pursuant to a 2014 Administrative Settlement Agreement and Order on Consent (‘‘2014 AOC’’), along with declaratory judgments regarding UPCM’s liability for future costs to be incurred in responding to releases of hazardous substances at the Richardson Flat Tailings Site near Park City, Utah. Under the Consent Decree, UPCM agrees to pay or cause to be paid $6,475,000 for response costs at the Richardson Flat Tailings Site, $350,000 for natural resource damages at the Richardson Flat Tailings Site, and $250,000 for response costs at the nearby Uintah Mining District Site. In return, the United States agrees not to sue UPCM and certain other entities E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 87, Number 168 (Wednesday, August 31, 2022)]
[Notices]
[Pages 53494-53502]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18794]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-372]


Exempt Chemical Preparations Under the Controlled Substances Act

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Order with opportunity for comment.

-----------------------------------------------------------------------

SUMMARY: The applications for exempt chemical preparations received by 
the Drug Enforcement Administration (DEA) between August 30, 2021, and 
March 31, 2022, as listed below, were accepted for filing and have been 
approved or denied as indicated.

DATES: Interested persons may file written comments on this order in 
accordance with 21 CFR 1308.23(e). Electronic comments must be 
submitted, and written comments must be postmarked, on or before 
October 31, 2022. Commenters should be aware that the electronic 
Federal Docket Management System will not accept comments after 11:59 
p.m. eastern time on the last day of the comment period.

ADDRESSES: To ensure proper handling of comments, please reference 
``Docket No. DEA-372'' on all correspondence, including any 
attachments.
    Electronic comments: DEA encourages that all comments be submitted 
through the Federal eRulemaking Portal, which provides the ability to 
type short comments directly into the comment field on the web page or 
to attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for 
submitting comments. Upon completion of your submission you will 
receive a Comment Tracking Number for your comment. Please be aware 
that submitted comments are not instantaneously available for public 
view on Regulations.gov. If you have received a comment tracking 
number, your comment has been successfully submitted and there is no 
need to resubmit the same comment.
    Paper comments: Paper comments that duplicate the electronic 
submission are not necessary and are discouraged. Should you wish to 
mail a comment in lieu of an electronic comment, it should be sent via 
regular or express mail to: Drug Enforcement Administration, Attention: 
DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Diversion 
Control Division, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 
362-8201.

SUPPLEMENTARY INFORMATION:

Posting of Public Comments

    Please note that all comments received are considered part of the 
public record and made available for public inspection online at http:/
/

[[Page 53495]]

www.regulations.gov and in the DEA's public docket. Such information 
includes personal identifying information (such as your name, address, 
etc.) voluntarily submitted by the commenter. The Freedom of 
Information Act applies to all comments received.
    If you want to submit personal identifying information (such as 
your name, address, etc.) as part of your comment, but do not want it 
to be posted online or made available in the public docket, you must 
include the phrase ``PERSONAL IDENTIFYING INFORMATION'' in the first 
paragraph of your comment. You must also place all the personal 
identifying information you do not want posted online or made available 
in the public docket in the first paragraph of your comment and 
identify what information you want redacted.
    If you want to submit confidential business information as part of 
your comment, but do not want it to be posted online or made available 
in the public docket, you must include the phrase ``CONFIDENTIAL 
BUSINESS INFORMATION'' in the first paragraph of your comment. You must 
also prominently identify confidential business information to be 
redacted within the comment.
    Comments containing personal identifying information and 
confidential business information identified as directed above will 
generally be made publicly available in redacted form. If a comment has 
so much confidential business information that it cannot be effectively 
redacted, all or part of that comment may not be made publicly 
available. Comments posted to https://www.regulations.gov may include 
any personal identifying information (such as name, address, and phone 
number) included in the text of your electronic submission that is not 
identified as directed above as confidential.
    An electronic copy of this document is available at https://www.regulations.gov for easy reference.

Legal Authority

    Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) 
authorizes the Attorney General, by regulation, to exempt from certain 
provisions of the CSA certain compounds, mixtures, or preparations 
containing a controlled substance, if he finds that such compounds, 
mixtures, or preparations meet the requirements detailed in 21 U.S.C. 
811(g)(3)(B).\1\ The Drug Enforcement Administration (DEA) regulations 
at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the 
DEA Assistant Administrator may exempt a chemical preparation or 
mixture from certain provisions of the CSA. The Assistant Administrator 
may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by 
which exemptions are granted and modify the scope of exemptions at any 
time.
---------------------------------------------------------------------------

    \1\ This authority has been delegated from the Attorney General 
to the DEA Administrator by 28 CFR 0.100, and subsequently 
redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 
0.104 and section 7 of the appendix to subpart R of part 0.
---------------------------------------------------------------------------

Exempt Chemical Preparation Applications Submitted Between August 30, 
2021, and March 31, 2022

    DEA received applications between August 30, 2021, and March 31, 
2022, requesting exempt chemical preparation status detailed in 21 CFR 
1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and 
in 21 CFR 1308.23, the Assistant Administrator has found that each of 
the compounds, mixtures, and preparations described in Chart I below is 
intended for laboratory, industrial, educational, or special research 
purposes and not for general administration to a human being or animal 
and either: (1) contains no narcotic controlled substance and is 
packaged in such a form or concentration that the packaged quantity 
does not present any significant potential for abuse; or (2) contains 
either a narcotic or non-narcotic controlled substance and one or more 
adulterating or denaturing agents in such a manner, combination, 
quantity, proportion, or concentration that the preparation or mixture 
does not present any potential for abuse and, if the preparation or 
mixture contains a narcotic controlled substance, is formulated in such 
a manner that it incorporates methods of denaturing or other means so 
that the preparation or mixture is not liable to be abused or have ill 
effects, if abused, and so that the narcotic substance cannot in 
practice be removed.
    Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, 
and 21 CFR 1308.24, the Assistant Administrator has determined that 
each of the chemical preparations or mixtures generally described in 
Chart I below and specifically described in the application materials 
received by DEA is exempt, to the extent described in 21 CFR 1308.24, 
from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 
1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, 
and 21 CFR 1301.74, as of the date that was provided in the approval 
letters to the individual requesters.

Scope of Approval

    The exemptions are applicable only to the precise preparation or 
mixture described in the application submitted to DEA in the form(s) 
listed in this order and only for those above mentioned sections of the 
CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in 
the quantitative or qualitative composition of the preparation or 
mixture, or change in the trade name or other designation of the 
preparation or mixture after the date of application requires a new 
application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply 
to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA 
may prescribe requirements other than those set forth in 21 CFR 
1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk 
quantities. Accordingly, in order to limit opportunity for diversion 
from the larger bulk quantities, DEA has determined that each of the 
exempted bulk products listed in this order may only be used in-house 
by the manufacturer, and may not be distributed for any purpose, or 
transported to other facilities.
    Additional exempt chemical preparation requests received between 
August 30, 2021, and March 31, 2022, and not otherwise referenced in 
this order, may remain under consideration until DEA receives 
additional information required, pursuant to 21 CFR 1308.23(d), as 
detailed in separate correspondence to individual requesters. DEA's 
order on such requests will be communicated to the public in a future 
Federal Register publication.
    DEA also notes that these exemptions are limited to exemption from 
only those sections of the CSA and the CFR that are specifically 
identified in 21 CFR 1308.24(a). All other requirements of the CSA and 
the CFR apply, including registration as an importer as required by 21 
U.S.C. 957.

[[Page 53496]]



                                                     Chart I
----------------------------------------------------------------------------------------------------------------
                                                                                                    Application
               Supplier                          Product name                     Form                 date
----------------------------------------------------------------------------------------------------------------
Aalto Scientific, Ltd.................  Unassayed Chemistry Base Level  Glass or plastic bottle        3/28/2022
                                         1.                              or flask: 1mL-100 mL;
                                                                         100mL-500mL; 500mL-1L.
Aalto Scientific, Ltd.................  Unassayed Chemistry Base Level  Glass or plastic bottle        3/28/2022
                                         2.                              or flask: 1mL-100 mL;
                                                                         100mL-500mL; 500mL-1L.
Aalto Scientific, Ltd.................  Unassayed Chemistry Base Level  Glass or plastic bottle        3/28/2022
                                         3.                              or flask: 1mL-100 mL;
                                                                         100mL-500mL; 500mL-1L.
Absolute Standards, Inc...............  (-)-[Delta]8-THC-D3, 100 ug/    Glass ampoule: 1 mL.....       2/14/2022
                                         mL, in Methanol.
Absolute Standards, Inc...............  (-)-[Delta]9-THC-D3, 100 ug/    Glass ampoule: 1 mL.....       2/14/2022
                                         mL, in Ethanol.
Absolute Standards, Inc...............  (-)-[Delta]9-THC-D3, 1000 ug/   Glass ampoule: 1 mL.....       2/14/2022
                                         mL, in Ethanol.
Absolute Standards, Inc...............  (+/-)-11-Hydroxy-[Delta]9-THC-  Glass ampoule: 1 mL.....       2/14/2022
                                         D3, 100 ug/mL, in Methanol.
Absolute Standards, Inc...............  (+/-)-11-Hydroxy-[Delta]9-THC-  Glass ampoule: 1 mL.....       2/14/2022
                                         D3, 1000 ug/mL, in Methanol.
Absolute Standards, Inc...............  (+/-)-Amphetamine-D8, 10 ug/    Glass ampoule: 1 mL.....       2/14/2022
                                         mL, in Methanol.
Absolute Standards, Inc...............  (+/-)-Amphetamine-D8, 100 ug/   Glass ampoule: 1 mL.....       2/14/2022
                                         mL, in Methanol.
Absolute Standards, Inc...............  (+/-)-Amphetamine-D8, 1000 ug/  Glass ampoule: 1 mL.....       2/14/2022
                                         mL, in Methanol.
Absolute Standards, Inc...............  (+/-)-Methamphetamine-D8, 100   Glass ampoule: 1 mL.....       2/14/2022
                                         ug/mL, in Methanol.
Absolute Standards, Inc...............  (+/-)-Methamphetamine-D8, 1000  Glass ampoule: 1 mL.....       2/14/2022
                                         ug/mL, in Methanol.
Absolute Standards, Inc...............  (+/-)-Methamphetamine-D9, 1000  Glass ampoule: 1 mL.....       2/14/2022
                                         ug/mL, in Methanol.
Absolute Standards, Inc...............  AB-CHMINACA, 100 ug/mL, in      Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  AB-FUBINACA, 100 ug/mL, in      Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  AB-PINACA, 100 ug/mL, in        Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  AH-7921, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  AKB48 (APINACA), 100 ug/mL, in  Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  alpha-Pyrrolidinobutiophenone   Glass ampoule: 1 mL.....       2/14/2022
                                         (alpha-PBP), 100 ug/mL, in
                                         Methanol.
Absolute Standards, Inc...............  AM2201, 100 ug/mL, in           Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  AM2201, 100 ug/mL, in Methanol  Glass ampoule: 1 mL.....       2/14/2022
Absolute Standards, Inc...............  Benzoylecgonine, 10 ug/ml, in   Glass ampoule: 1 ml.....       1/10/2022
                                         Methanol.
Absolute Standards, Inc...............  Benzoylecgonine, 100 ug/ml, in  Glass ampoule: 1 ml.....       1/10/2022
                                         Methanol.
Absolute Standards, Inc...............  Benzoylecgonine, 1000 ug/ml,    Glass ampoule: 1 ml.....       1/10/2022
                                         in Methanol.
Absolute Standards, Inc...............  Benzoylecgonine-D8, 100 ug/ml,  Glass ampoule: 1 ml.....       1/10/2022
                                         in Methanol.
Absolute Standards, Inc...............  Benzoylecgonine-D8, 1000 ug/    Glass ampoule: 1 ml.....       1/10/2022
                                         ml, in Methanol.
Absolute Standards, Inc...............  Cocaine-D3, 10 ug/ml, in        Glass ampoule: 1 ml.....       1/10/2022
                                         Methanol.
Absolute Standards, Inc...............  Cocaine-D3, 100 ug/ml, in       Glass ampoule: 1 ml.....       1/10/2022
                                         Methanol.
Absolute Standards, Inc...............  Cocaine-D3, 1000 ug/ml, in      Glass ampoule: 1 ml.....       1/10/2022
                                         Methanol.
Absolute Standards, Inc...............  Codeine-6-[beta]-glucuronide,   Glass ampoule: 1 ml.....       1/10/2022
                                         10 ug/ml, in
                                         acetonitrile:water [1:1].
Absolute Standards, Inc...............  Codeine-6-[beta]-glucuronide,   Glass ampoule: 1 ml.....       1/10/2022
                                         100 ug/ml, in
                                         acetonitrile:water [1:1].
Absolute Standards, Inc...............  Codeine-6-[beta]-glucuronide,   Glass ampoule: 1 ml.....       1/10/2022
                                         1000 ug/ml, in
                                         acetonitrile:water [1:1].
Absolute Standards, Inc...............  d,l-MDEA, 10 ug/ml, in          Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  d,l-MDEA, 100 ug/ml, in         Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  d,l-MDEA, 1000 ug/ml, in        Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  d,l-Methadone, 10 ug/ml, in     Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  d,l-Methadone, 100 ug/ml, in    Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  d,l-Methadone, 1000 ug/ml, in   Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  d,l-Methadone-D3, 10 ug/ml, in  Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  d,l-Methadone-D3, 100 ug/ml,    Glass ampoule: 1 ml.....       1/10/2022
                                         in methanol.
Absolute Standards, Inc...............  d,l-Methadone-D3, 1000 ug/ml,   Glass ampoule: 1 ml.....       1/10/2022
                                         in methanol.
Absolute Standards, Inc...............  DBP Mix, 100 ug/ml, in MTBE...  Glass ampoule: 1 ml.....       1/10/2022
Absolute Standards, Inc...............  DBP Mix, 100 ug/ml, in MTBE...  Glass ampoule: 1 ml.....       1/10/2022
Absolute Standards, Inc...............  Dimethyltryptamine, 100 ug/ml,  Glass ampoule: 1 ml.....       1/10/2022
                                         in methanol.
Absolute Standards, Inc...............  Dimethyltryptamine, 1000 ug/    Glass ampoule: 1 ml.....       1/10/2022
                                         ml, in methanol.
Absolute Standards, Inc...............  d-Propoxyphene, 100 ug/mL, in   Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  d-Propoxyphene, 1000 ug/mL, in  Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Ecognine methyl ester, 10 ug/   Glass ampoule: 1 ml.....       1/10/2022
                                         ml, in methanol.
Absolute Standards, Inc...............  Ecognine methyl ester, 100 ug/  Glass ampoule: 1 ml.....       1/10/2022
                                         ml, in methanol.
Absolute Standards, Inc...............  Ecognine methyl ester, 1000 ug/ Glass ampoule: 1 ml.....       1/10/2022
                                         ml, in methanol.
Absolute Standards, Inc...............  EPA Method 551 ``Mix B'', 1000  Glass ampoule: 1 ml x 5.       1/10/2022
                                         ug/ml, in MTBE.
Absolute Standards, Inc...............  EPA Method 551--Disinfection    Glass ampoule: 1 ml.....       1/10/2022
                                         By-Products Mix #2, 100 ug/
                                         ml, in MTBE.
Absolute Standards, Inc...............  EPA Method 551.1--Analytes Mix  Glass ampoule: 1 ml.....       1/10/2022
                                         #2, 100 ug/ml, in MTBE.
Absolute Standards, Inc...............  Fenproporex, 1000 ug/mL, in     Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.

[[Page 53497]]

 
Absolute Standards, Inc...............  Fenproporex-D5, 1000 ug/mL, in  Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  FUB-144, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  FUB-AKB48 (FUB-APINACA), 100    Glass ampoule: 1 mL.....       2/14/2022
                                         ug/mL, in Methanol.
Absolute Standards, Inc...............  Heroin-D9, 10 ug/ml, in         Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Heroin-D9, 100 ug/ml, in        Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Heroin-D9, 1000 ug/ml, in       Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Hydrocodone (+)-bitartrate      Glass ampoule: 1 ml.....       1/10/2022
                                         salt, 100 ug/ml, in methanol.
Absolute Standards, Inc...............  Hydrocodone (+)-bitartrate      Glass ampoule: 1 ml.....       1/10/2022
                                         salt, 1000 ug/ml, in methanol.
Absolute Standards, Inc...............  Hydrocodone, 10 ug/ml, in       Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Hydrocodone, 100 ug/ml, in      Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Hydrocodone, 1000 ug/ml, in     Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Hydromorphone, 100 ug/ml, in    Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Hydromorphone, 1000 ug/ml, in   Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  JWH-019, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  JWH-073, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  JWH-073, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  JWH-081, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  JWH-122, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  JWH-200, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  JWH-200-d5, 100 ug/mL, in       Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  JWH-250, 100 ug/mL, in          Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Ketamine, 100 ug/mL, in         Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Ketamine, 1000 ug/mL, in        Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Ketamine-D4, 1000 ug/mL, in     Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Lysergic acid diethylamide      Glass ampoule: 1 mL.....       2/14/2022
                                         (LSD), 100 ug/mL, in
                                         Acetonitrile.
Absolute Standards, Inc...............  Lysergic acid diethylamide      Glass ampoule: 1 mL.....       2/14/2022
                                         (LSD), 100 ug/mL, in
                                         Acetonitrile.
Absolute Standards, Inc...............  Lysergic acid diethylamide      Glass ampoule: 1 mL.....       2/14/2022
                                         (LSD), 1000 ug/mL, in
                                         Acetonitrile.
Absolute Standards, Inc...............  Lysergic acid diethylamide      Glass ampoule: 1 mL.....       2/14/2022
                                         (LSD), 1000 ug/mL, in
                                         Acetonitrile.
Absolute Standards, Inc...............  Meperidine, 10 ug/ml, in        Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Meperidine, 100 ug/ml, in       Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Meperidine, 1000 ug/ml, in      Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Mephedrone, 100 ug/ml, in       Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Mephedrone, 1000 ug/ml, in      Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Mix A, 1000 ug/ml, in MTBE....  Glass ampoule: 1 ml.....       1/10/2022
Absolute Standards, Inc...............  MMB-FUBINACA, 100 ug/mL, in     Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  MMB-FUBINACA, 100 ug/mL, in     Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Nitrazepam, 100 ug/mL, in       Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  Nitrazepam, 1000 ug/mL, in      Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  NM2201, 100 ug/mL, in           Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  Oxazepam, 10 ug/ml, in          Glass ampoule: 1 ml.....       1/10/2022
                                         acetonitrile.
Absolute Standards, Inc...............  Oxazepam, 10 ug/ml, in          Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Oxazepam, 100 ug/ml, in         Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Oxazepam, 1000 ug/ml, in        Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Oxycodone, 10 ug/ml, in         Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Oxycodone, 100 ug/ml, in        Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Oxycodone, 1000 ug/ml, in       Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Oxycodone-D3, 100 ug/mL, in     Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Oxycodone-D3, 1000 ug/mL, in    Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Oxycodone-D6, 100 ug/mL, in     Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Oxycodone-D6, 1000 ug/mL, in    Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Oxymorphone, 100 ug/mL, in      Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Oxymorphone, 1000 ug/mL, in     Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Oxymorphone-D3, 100 ug/mL, in   Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Oxymorphone-D3, 1000 ug/mL, in  Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  PB-22, 100 ug/mL, in            Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  Phencyclidine-D5, 100 ug/mL,    Glass ampoule: 1 mL.....       2/14/2022
                                         in Methanol.
Absolute Standards, Inc...............  Phencyclidine-D5, 1000 ug/mL,   Glass ampoule: 1 mL.....       2/14/2022
                                         in Methanol.
Absolute Standards, Inc...............  Phenylacetone, 1000 ug/mL, in   Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Pregabalin, 10 ug/mL, in        Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Pregabalin, 100 ug/mL, in       Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Pregabalin, 1000 ug/mL, in      Glass ampoule: 1 mL.....       2/14/2022
                                         Methanol.
Absolute Standards, Inc...............  Psilocin, 100 ug/ml, in         Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Psilocin, 1000 ug/ml, in        Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Psilocybin PT, varied ug/ml,    Glass ampoule: 1 ml.....       1/10/2022
                                         in methanol.
Absolute Standards, Inc...............  RCS-4, 100 ug/mL, in Methanol.  Glass ampoule: 1 mL.....       2/14/2022

[[Page 53498]]

 
Absolute Standards, Inc...............  THC-O-acetate, 100 ug/ml, in    Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  THC-O-acetate, 1000 ug/ml, in   Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  THC-O-acetate, varied ug/ml,    Glass ampoule: 1 ml.....       1/10/2022
                                         in methanol.
Absolute Standards, Inc...............  Tramadol, 10 ug/ml, in          Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  Tramadol, 100 ug/ml, in         Glass ampoule: 1 ml.....       1/10/2022
                                         methanol.
Absolute Standards, Inc...............  UR-144, 100 ug/mL, in Methanol  Glass ampoule: 1 mL.....       2/14/2022
Absolute Standards, Inc...............  XLR-11, 100 ug/mL, in Methanol  Glass ampoule: 1 mL.....       2/14/2022
Absolute Standards, Inc...............  Zopiclone, 100 ug/mL, in        Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Absolute Standards, Inc...............  Zopiclone, 1000 ug/mL, in       Glass ampoule: 1 mL.....       2/14/2022
                                         Acetonitrile.
Audit MicroControls, Inc..............  Control FLQ Unassayed           Kit: 10 bottles, 4 mL          3/30/2022
                                         Chemistry, Level 1.             each.
Audit MicroControls, Inc..............  Control FLQ Unassayed           Kit: 5 bottles, 4 mL           3/30/2022
                                         Chemistry, Level 1.             each.
Audit MicroControls, Inc..............  Control FLQ Unassayed           Plastic bottle: 4mL.....       3/30/2022
                                         Chemistry, Level 1.
Cerilliant Corporation................  (6aR,9R)-delta10-THC..........  Glass ampule: 1.0 mL....       8/30/2021
Cerilliant Corporation................  5 Part Potency in Beverage....  Glass ampule: 1.0 mL....       2/22/2022
Cerilliant Corporation................  6 Part Potency in Solution      Glass ampule: 1.0 mL....       1/11/2022
                                         (Acids).
Cerilliant Corporation................  8 Part Potency in Solution      Glass ampule: 1.0 mL....       1/11/2022
                                         (Neutrals).
Chemtos, LLC..........................  (S)-N,N-dimethylamphetamine     Amber ampule: 1 mL......       3/14/2022
                                         HCl (1 mg/mL in methanol).
Chemtos, LLC..........................  (S)-N,N-dimethylamphetamine-d3  Amber ampule: 1 mL......       3/14/2022
                                         HCl (0.1 mg/mL in methanol).
Chemtos, LLC..........................  (S)-N,N-dimethylamphetamine-d3  Amber ampule: 1 mL......       3/14/2022
                                         HCl (1 mg/mL in methanol).
Chemtos, LLC..........................  2,4-DMMC HCl (1 mg/mL in        Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  3,4-DMMC HCl (1 mg/mL in        Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  3-MMC HCl (1 mg/mL in           Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  4-Cl-PVP HCl (1 mg/mL in        Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  4-Methylbuphedrone (4-Me-MABP)  Amber ampule: 1 mL......       3/14/2022
                                         HCl (1 mg/mL in methanol).
Chemtos, LLC..........................  5F-MDMB-PICA (1 mg/mL in        Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  AB-CHMINACA (1 mg/mL in         Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  AB-PINACA (1 mg/mL in           Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  alpha-PHP HBr (1 mg/mL in       Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Alphaprodine HCl (1 mg/mL in    Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Alphaprodine-d5 HCl (0.1 mg/mL  Amber ampule: 1 mL......       3/14/2022
                                         in methanol).
Chemtos, LLC..........................  Alphaprodine-d5 HCl (1 mg/mL    Amber ampule: 1 mL......       3/14/2022
                                         in methanol).
Chemtos, LLC..........................  AM-694 (1 mg/mL in              Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  Anileridine HCl (1 mg/mL in     Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  APINACA, AKB48 (1 mg/mL in      Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  bk-MDDMA HCl (Dimethylone) (1   Amber ampule: 1 mL......       3/14/2022
                                         mg/mL in methanol).
Chemtos, LLC..........................  Diethyltryptamine (DET) (1 mg/  Amber ampule: 1 mL......       3/14/2022
                                         mL in methanol).
Chemtos, LLC..........................  Dimethyltryptamine (DMT) (1 mg/ Amber ampule: 1 mL......       3/14/2022
                                         mL in methanol).
Chemtos, LLC..........................  Dimethyltryptamine-d3 (DMT-d3)  Amber ampule: 1 mL......       3/14/2022
                                         (0.1 mg/mL in methanol).
Chemtos, LLC..........................  Dimethyltryptamine-d3 (DMT-d3)  Amber ampule: 1 mL......       3/14/2022
                                         (1 mg/mL in methanol).
Chemtos, LLC..........................  Dipentylone HCl (bk-DMBDP) (1   Amber ampule: 1 mL......       3/14/2022
                                         mg/mL in methanol).
Chemtos, LLC..........................  Estazolam (1 mg/mL in           Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Estazolam-d5 (0.1 mg/mL in      Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Estazolam-d5 (1 mg/mL in        Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Flunitrazepam (1 mg/mL in       Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Flunitrazepam-d3 (0.1 mg/mL in  Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Flunitrazepam-d3 (1 mg/mL in    Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Ketamine HCl (1 mg/mL in        Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Ketamine-d4 HCl (0.1 mg/mL in   Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Ketamine-d4 HCl (1 mg/mL in     Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  MAB-CHMINACA (1 mg/mL in        Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  MDMB-CHMICA, MMB-CHMINACA (1    Amber ampule: 1 mL......       3/14/2022
                                         mg/mL in acetonitrile).
Chemtos, LLC..........................  MMB-CHMICA, AMB-CHMICA (1 mg/   Amber ampule: 1 mL......       3/14/2022
                                         mL in acetonitrile).
Chemtos, LLC..........................  MPHP HCl (1 mg/mL in methanol)  Amber ampule: 1 mL......       3/14/2022
Chemtos, LLC..........................  Naphyrone HCl (1 mg/mL in       Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  N-Ethyl-amphetamine HCl (1 mg/  Amber ampule: 1 mL......       3/14/2022
                                         mL in methanol).
Chemtos, LLC..........................  N-Ethyl-amphetamine-d5 HCl      Amber ampule: 1 mL......       3/14/2022
                                         (0.1 mg/mL in methanol).
Chemtos, LLC..........................  N-ethylhexedrone (NEH) HCl (1   Amber ampule: 1 mL......       3/14/2022
                                         mg/mL in methanol).
Chemtos, LLC..........................  N-ethylhexedrone-d5 (NEH-d5)    Amber ampule: 1 mL......       3/14/2022
                                         HCl (0.1 mg/mL in methanol).
Chemtos, LLC..........................  NM2201, CBL-2201 (1 mg/mL in    Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  PCC (1 mg/mL in acetonitrile).  Amber ampule: 1 mL......       3/14/2022
Chemtos, LLC..........................  Phendimetrazine-d8 (0.1 mg/mL   Amber ampule: 1 mL......       3/14/2022
                                         in methanol).
Chemtos, LLC..........................  Phendimetrazine-d8 (1 mg/mL in  Amber ampule: 1 mL......       3/14/2022
                                         methanol).

[[Page 53499]]

 
Chemtos, LLC..........................  Phenylacetone (1 mg/mL in       Amber ampule: 1 mL......       3/14/2022
                                         acetonitrile).
Chemtos, LLC..........................  Propylone HCl (bk-3,4-MDPA) (1  Amber ampule: 1 mL......       3/14/2022
                                         mg/mL in methanol).
Chemtos, LLC..........................  PV8 (PHPP) HCl (1 mg/mL in      Amber ampule: 1 mL......       3/14/2022
                                         methanol).
Chemtos, LLC..........................  Tenocyclidine (TCP) (1 mg/mL    Amber ampule: 1 mL......       3/14/2022
                                         in methanol).
Chemtos, LLC..........................  THJ-2201 (AM2201) (1 mg/mL in   Amber ampule: 1 mL......       3/14/2022
                                         methanol).
CPI International.....................  Custom Hormone Mix, 9-072,      Amber ampule: 1 mL......        2/2/2022
                                         1000 mg/L, 1 mL (ISO 17025).
LabSystems Diagnostics................  NeoMass CAH Extraction          Glass vial: 33 mL.......       1/10/2022
                                         Solution with Internal
                                         Standard.
LabSystems Diagnostics................  NeoMass CAH Mutlilevel          Aluminum pouch: 7 Dried        1/10/2022
                                         Calibrator Dried Blood Spot     blood spots, 85
                                         Calibrator Level 0-7.           [micro]L each.
LabSystems Diagnostics................  NeoMass CAH Mutlilevel          Aluminum pouch: 6 Dried        1/10/2022
                                         Controls Dried Blood Spot       blood spots, 85
                                         Controls Level 1-3.             [micro]L each.
LabSystems Diagnostics................  NeoMass CAH System suitability  Glass vial: 2 mL........       1/10/2022
                                         Mixture CAH (lyophilized).
LabSystems Diagnostics................  NeoMass CAH Tuning Mixture CAH  Glass vial: 2 mL........       1/10/2022
                                         (lyophilized).
LGC...................................  Narcotics Mixture 1 0.02-0.075  1 kit; 10 x 1 mL amber          3/8/2022
                                         [mu]g/mL in Synthetic oral      cryule.
                                         fluid.
LGC...................................  Narcotics Mixture 2 0.01-0.05   1 kit; 10 x 1 mL amber          3/8/2022
                                         [mu]g/mL in Synthetic oral      cryule.
                                         fluid.
LGC...................................  Narcotics Mixture 3 0.001-0.01  1 kit; 10 x 1 mL amber          3/8/2022
                                         [mu]g/mL in Synthetic oral      cryule.
                                         fluid.
LGC--Dr. Ehrenstorfer.................  (6aR,9R)-[Delta]10-             Amber Ampule: 1 mL......      12/21/2021
                                         Tetrahydrocannabinol 100
                                         [mu]g/mL in Methanol.
LGC--Dr. Ehrenstorfer.................  (6aR-trans)-[Delta]8-           Amber Ampule: 1 mL......      12/21/2021
                                         Tetrahydrocannabinol acetate
                                         100 [mu]g/mL in Methanol.
LGC--Dr. Ehrenstorfer.................  Custom Cannabinoid Mixture      Amber ampule: 1 mL......        3/4/2022
                                         10141 1000 ug/mL in
                                         Acetonitrile.
LGC--Dr. Ehrenstorfer.................  Custom Cannabinoid Mixture      1 kit; 5 x 1 mL amber           3/4/2022
                                         10142 1000 ug/mL in             ampule.
                                         Acetonitrile.
LGC--Dr. Ehrenstorfer.................  Custom Pharmaceutical Mixture   Amber ampule: 1 mL......        3/4/2022
                                         10147 1000 ug/mL in
                                         Acetonitrile.
LGC--Dr. Ehrenstorfer.................  Custom Pharmaceutical Mixture   1 kit; 5 x 1 mL amber           3/4/2022
                                         10148 1000 ug/mL in             ampule.
                                         Acetonitrile.
LGC--Dr. Ehrenstorfer.................  Custom Tramadol hydrochloride   Glass Ampule: 1 mL......       1/27/2022
                                         100 [mu]g/mL in Methanol.
LGC--Dr. Ehrenstorfer.................  Trenbolone                      Amber Ampule: 1 mL......      12/21/2021
                                         cyclohexylmethylcarbonate 100
                                         [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer.................  Zolpidem tartrate 100 [mu]g/mL  Glass Ampule: 1 mL......       1/27/2022
                                         in Methanol.
LGC Clinical Diagnostics, Inc.........  Fertility 1 ab Bulk--Level 1..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 ab Bulk--Level 2..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 ab Bulk--Level 3..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 ab Bulk--Level 4..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 ab Bulk--Level 5..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 ab WrkBlk--Level 1  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 ab WrkBlk--Level 5  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 re Bulk--Level 1..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 re Bulk--Level 2..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 re Bulk--Level 3..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 re Bulk--Level 4..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 re Bulk--Level 5..  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 re WrkBlk--Level 1  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  Fertility 1 re WrkBlk--Level 5  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ab Bulk--Level 1.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ab Bulk--Level 2.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ab Bulk--Level 3.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ab Bulk--Level 4.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ab Bulk--Level 5.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ab WrkBlk--Level 1.......  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 au Bulk--Level 1.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 au Bulk--Level 2.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 au Bulk--Level 3.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 au Bulk--Level 4.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 au Bulk--Level 5.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 au WrkBlk--Level 1.......  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.

[[Page 53500]]

 
LGC Clinical Diagnostics, Inc.........  TDM1 bc Bulk--Level 1.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 bc Bulk--Level 2.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 bc Bulk--Level 3.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 bc Bulk--Level 4.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 bc Bulk--Level 5.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 bc WrkBlk--Level 1.......  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 db Bulk--Level 1.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 db Bulk--Level 2.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 db Bulk--Level 3.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 db Bulk--Level 4.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 db Bulk--Level 5.........  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 db WrkBlk--Level 1.......  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri GentC Set Bulk--Level   Volumetric flask: 3200         3/21/2022
                                         1.                              mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri GentC Set Bulk--Level   Volumetric flask: 3200         3/21/2022
                                         2.                              mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri GentC Set Bulk--Level   Volumetric flask: 3200         3/21/2022
                                         3.                              mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri GentC Set Bulk--Level   Volumetric flask: 3200         3/21/2022
                                         4.                              mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri GentC Set Bulk--Level   Volumetric flask: 3200         3/21/2022
                                         5.                              mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri GentC Set WrkBlk--      Volumetric flask: 200-         3/21/2022
                                         Level 1.                        8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri TDM Set Bulk--Level 1.  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri TDM Set Bulk--Level 2.  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri TDM Set Bulk--Level 3.  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri TDM Set Bulk--Level 4.  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri TDM Set Bulk--Level 5.  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri TDM Set WrkBlk--Level   Volumetric flask: 200-         3/21/2022
                                         1.                              8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 vt Set Bulk--Level 1.....  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 vt Set Bulk--Level 2.....  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 vt Set Bulk--Level 3.....  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 vt Set Bulk--Level 4.....  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 vt Set Bulk--Level 5.....  Volumetric flask: 3200         3/21/2022
                                                                         mL.
LGC Clinical Diagnostics, Inc.........  TDM1 vt Set WrkBlk--Level 1...  Volumetric flask: 200-         3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  Testosterone (TSTO) Stock A     Plastic vial: 25 mL.....       3/21/2022
                                         100,000 ng/ml.
LGC Clinical Diagnostics, Inc.........  Testosterone (TSTO) Stock B     Plastic vial: 25 mL.....       3/21/2022
                                         2,000 ng/ml.
LGC Clinical Diagnostics, Inc.........  VALIDATE Fertility 1 Test Set   5 Bottles: 4 mL each....       3/21/2022
                                         502ab.
LGC Clinical Diagnostics, Inc.........  VALIDATE Fertility 1 Test Set   5 Bottles: 4 mL each....       3/21/2022
                                         502re.
LGC Clinical Diagnostics, Inc.........  VALIDATE TDM1 Test Set 301ab..  Kit: 5 Bottles, 3 ml           3/21/2022
                                                                         each.
LGC Clinical Diagnostics, Inc.........  VALIDATE TDM1 Test Set 301au..  Kit: 5 Bottles, 3 ml           3/21/2022
                                                                         each.
LGC Clinical Diagnostics, Inc.........  VALIDATE TDM1 Test Set 301bc..  Kit: 5 Bottles, 3 ml           3/21/2022
                                                                         each.
LGC Clinical Diagnostics, Inc.........  VALIDATE TDM1 Test Set 301db..  Kit: 5 Bottles, 3 ml           3/21/2022
                                                                         each.
LGC Clinical Diagnostics, Inc.........  VALIDATE TDM1 Test Set 301ri..  Kit: 5 Bottles, 3 ml           3/21/2022
                                                                         each; 5 bottles, 2 mL
                                                                         each.
LGC Clinical Diagnostics, Inc.........  VALIDATE TDM1 Test Set 301vt..  Kit: 5 Bottles, 3 ml           3/21/2022
                                                                         each.
o2si smart solutions..................  Custom Pharmaceutical Mixture,  1 Package; 5 x 1 mL            1/14/2022
                                         12-0370, 100 ug/mL, 5 x 1 mL    amber ampules.
                                         (ISO 17034).
o2si smart solutions..................  Hydrocodone hydrogen (+)-       Amber ampule: 1 mL......       2/11/2022
                                         bitartrate as hydrocodone in
                                         acetonitrile Solution, 5,000
                                         mg/L PARENT STOCK SOLUTION--
                                         NOT FOR SALE.
Restek Corporation....................  Custom Heroin Standard........  Glass ampule: 1.3 mL....        3/8/2022
RTI International.....................  12198-62-06...................  Glass tube: 7 mL........        3/1/2022
RTI International.....................  2023 DMPM-01..................  HDPE Bottle: 40 mL......       3/30/2022
RTI International.....................  2023 DMPM-02..................  HDPE Bottle: 40 mL......       3/30/2022
RTI International.....................  2023 DMPM-03..................  HDPE Bottle: 40 mL......       3/30/2022
RTI International.....................  2023 DMPM-05..................  HDPE Bottle: 40 mL......       3/30/2022
RTI International.....................  2023 DMPM-06..................  HDPE Bottle: 40 mL......       3/30/2022
RTI International.....................  2023 DMPM-07..................  HDPE Bottle: 40 mL......       3/30/2022
RTI International.....................  2023 FTC-02...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-03...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-05...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-06...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-07...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-09...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-10...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-11...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-13...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-14...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 FTC-15...................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 OFD-01...................  Vial: 2 mL..............       3/30/2022

[[Page 53501]]

 
RTI International.....................  2023 OFD-02...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-03...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-04...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-05...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-06...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-07...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-08...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-10...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-11...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-12...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-13...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-14...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-15...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-16...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-17...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-18...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-19...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 OFD-20...................  Vial: 2 mL..............       3/30/2022
RTI International.....................  2023 T-02.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-03.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-04.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-05.....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 T-06.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-07.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-08.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-11.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-12.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 T-14.....................  HDPE Bottle: 20 mL......       3/30/2022
RTI International.....................  2023 THCB-01..................  Vial: 10 mL.............       3/30/2022
RTI International.....................  2023 THCB-02..................  Vial: 10 mL.............       3/30/2022
RTI International.....................  2023 THCB-03..................  Vial: 10 mL.............       3/30/2022
RTI International.....................  2023 THCB-04..................  Vial: 10 mL.............       3/30/2022
RTI International.....................  2023 THCB-05..................  Vial: 10 mL.............       3/30/2022
RTI International.....................  2023 THCB-06..................  Vial: 10 mL.............       3/30/2022
RTI International.....................  2023 UDS-01...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-02...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-03...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-04...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-05...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-06...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-07...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-08...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-09...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-10...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-11...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-12...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-13...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-14...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UDS-15...................  HDPE Bottle: 10 mL......       3/30/2022
RTI International.....................  2023 UT-01....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-02....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-03....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-05....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-06....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-07....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-08....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-09....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-10....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-11....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-12....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-13....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-14....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UT-15....................  HDPE Bottle: 50 mL......       3/30/2022
RTI International.....................  2023 UTCO-01..................  HDPE Bottle: 40 mL......       3/30/2022
RTI International.....................  2023 ZE-01....................  Vial: 5 mL..............       3/30/2022
RTI International.....................  2023 ZE-02....................  Vial: 5 mL..............       3/30/2022
RTI International.....................  2023 ZE-03....................  Vial: 5 mL..............       3/30/2022
RTI International.....................  2023 ZE-04....................  Vial: 5 mL..............       3/30/2022
RTI International.....................  2023 ZE-05....................  Vial: 5 mL..............       3/30/2022
RTI International.....................  2023 ZE-06....................  Vial: 5 mL..............       3/30/2022
RTI International.....................  2023-OFD-09...................  Vial: 2 mL..............       3/30/2022

[[Page 53502]]

 
RTI International.....................  Sample 1 Matrix: Urine........  HDPE tubes: 5 mL........        3/7/2022
RTI International.....................  Sample 2 Matrix: Urine........  HDPE tubes: 5 mL........        3/7/2022
RTI International.....................  Sample 3 Matrix: Plasma.......  HDPE tubes: 5 mL........        3/7/2022
RTI International.....................  Sample 4 Matrix: Urine........  HDPE tubes: 5 mL........        3/7/2022
RTI International.....................  Sample 6 Matrix: Whole Blood..  HDPE tubes: 5 mL........        3/7/2022
Thermo Fisher Scientific..............  Cascadion SM Antiepileptics     Box: 6 vials, 29 mL each       3/24/2022
                                         Internal Standard.
----------------------------------------------------------------------------------------------------------------

    The Assistant Administrator has found that each of the compounds, 
mixtures, and preparations described in Chart II below is not 
consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 
CFR 1308.23. Accordingly, the Assistant Administrator has determined 
that the chemical preparations or mixtures generally described in Chart 
II below and specifically described in the application materials 
received by DEA, are not exempt from application of any part of the CSA 
or from application of any part of the CFR, with regard to the 
requested exemption pursuant to 21 CFR 1308.23, as of the date that was 
provided in the determination letters to the individual requesters.

                                                    Chart II
----------------------------------------------------------------------------------------------------------------
                                                                                                    Application
               Supplier                          Product name                     Form                 date
----------------------------------------------------------------------------------------------------------------
Chemtos, LLC..........................  ANPP (1 mg/mL in acetonitrile)  Amber ampule: 1mL.......       3/14/2022
CPI International.....................  Custom Hormone Mix, 9-072,      1 Package; 6 x 1 mL            1/14/2022
                                         1000 mg/L, 6 x 1 ml.            amber ampules.
LGC Clinical Diagnostics, Inc.........  TDM1 ab WrkBlk--Level 5.......  Volumetric flask: 200--        3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 au WrkBlk--Level 5.......  Volumetric flask: 200--        3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 bc WrkBlk--Level 5.......  Volumetric flask: 200--        3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 db WrkBlk--Level 5.......  Volumetric flask: 200--        3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri GentC Set WrkBlk--      Volumetric flask: 200--        3/21/2022
                                         Level 5.                        8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 ri TDM Set WrkBlk--Level   Volumetric flask: 200--        3/21/2022
                                         5.                              8000 mL.
LGC Clinical Diagnostics, Inc.........  TDM1 vt Set WrkBlk--Level 5...  Volumetric flask: 200--        3/21/2022
                                                                         8000 mL.
LGC Clinical Diagnostics, Inc.........  Validate TDM Phenobarbital      Plastic vial: 150 mL....       3/21/2022
                                         Stock.
----------------------------------------------------------------------------------------------------------------

Opportunity for Comment

    Pursuant to 21 CFR 1308.23(e), any interested person may submit 
written comments on or objections to any chemical preparation in this 
order that has been approved or denied as exempt. If any comments or 
objections raise significant issues regarding any finding of fact or 
conclusion of law upon which this order is based, the Assistant 
Administrator will immediately suspend the effectiveness of any 
applicable part of this order until she may reconsider the application 
in light of the comments and objections filed. Thereafter, the 
Assistant Administrator shall reinstate, revoke, or amend his original 
order as she determines appropriate.

Approved Exempt Chemical Preparations are Posted on the DEA's Website

    A list of all current exemptions, including those listed in this 
order, is available on the DEA's website at https://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The 
dates of applications of all current exemptions are posted for easy 
reference.

Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-18794 Filed 8-30-22; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.